Gilead Sciences
GILD
#80
Rank
A$313.45 B
Marketcap
A$252.72
Share price
1.60%
Change (1 day)
33.05%
Change (1 year)

Earnings for Gilead Sciences (GILD)

Earnings in 2026 (TTM): -A$3.6 Billion

According to Gilead Sciences's latest financial reports the company's current earnings are A$30.98 Billion. In 2025 the company made an earning of A$14.54 Billion, an increase over its 2024 earnings that were of A$1.02 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Gilead Sciences from 1991 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$3.6 Billion-124.71%
2025 A$14.54 B1319.86%
2024 A$1.02 B-89.94%
2023 A$10.18 B17.97%
2022 A$8.62 B-29.77%
2021 A$12.28 B395.99%
2020 A$2.47 B-67.66%
2019 A$7.65 B-33.84%
2018 A$11.57 B-42.35%
2017 A$20.08 B-20.87%
2016 A$25.37 B-21.06%
2015 A$32.14 B45.8%
2014 A$22.05 B253.01%
2013 A$6.24 B16.51%
2012 A$5.36 B-1.07%
2011 A$5.41 B-6.71%
2010 A$5.80 B11.75%
2009 A$5.19 B29.5%
2008 A$4.01 B19.11%
2007 A$3.36 B-455.74%
2006 -A$0.95 Billion-154.93%
2005 A$1.72 B76.99%
2004 A$0.97 B-266.16%
2003 -A$0.59 Billion-638.24%
2002 A$0.10 B31.5%
2001 A$82.84 M-242.15%
2000 -A$58.29 Million-40.2%
1999 -A$97.47 Million31.85%
1998 -A$73.92 Million8.73%
1997 -A$67.99 Million27.22%
1996 -A$53.44 Million
1994 -A$50.92 Million26.57%
1993 -A$40.23 Million46.49%
1992 -A$27.46 Million362.5%
1991 -A$5.94 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$27.78 B-839.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$10.34 B-375.09%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$19.01 B-605.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$51.60 B-1,472.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$16.40 B-536.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$0.66 B-117.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$1.65 B-144.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
A$6.77 B-280.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$9.97 B-365.42%๐Ÿ‡บ๐Ÿ‡ธ USA